scispace - formally typeset
A

Anne S. Pohlman

Researcher at University of Chicago

Publications -  77
Citations -  12806

Anne S. Pohlman is an academic researcher from University of Chicago. The author has contributed to research in topics: Intensive care unit & Sedation. The author has an hindex of 39, co-authored 68 publications receiving 11690 citations. Previous affiliations of Anne S. Pohlman include MacLean Center for Clinical Medical Ethics.

Papers
More filters
Journal ArticleDOI

Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation

TL;DR: A randomized, controlled trial involving 128 adult patients who were receiving mechanical ventilation and continuous infusions of sedative drugs in a medical intensive care unit found that the intervention group increased the median duration of mechanical ventilation, as compared with 7.3 days in the control group.
Journal ArticleDOI

Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial.

TL;DR: A strategy for whole-body rehabilitation-consisting of interruption of sedation and physical and occupational therapy in the earliest days of critical illness-was safe and well tolerated, and resulted in better functional outcomes at hospital discharge, a shorter duration of delirium, and more ventilator-free days compared with standard care.
Journal ArticleDOI

The Long-term Psychological Effects of Daily Sedative Interruption on Critically Ill Patients

TL;DR: It is concluded that daily sedative interruption does not result in adverse psychological outcomes, reduces symptoms of PTSD, and may be associated with reductions in posttraumatic stress disorder.
Journal ArticleDOI

Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial

TL;DR: Treatment with helmet NIV resulted in a significant reduction of intubation rates among patients with ARDS and a statistically significant reduction in 90-day mortality.